Sign in

    Joanna Deetrup

    Research Analyst at Bank of America

    No verifiable professional information could be found for Joanna Deetrup as an analyst at Bank of America. As of now, there is no evidence of her holding an analyst or senior research position at the firm, nor any public record of coverage, performance metrics, or industry recognition in major financial databases and professional networks. Her LinkedIn profile is not found, and no details are available regarding her career timeline, previous employers, or professional credentials. Comprehensive research indicates Joanna Deetrup may not be a current public-facing analyst, or the name provided may be incorrect or does not correspond to a Bank of America analyst.

    Joanna Deetrup's questions to Oscar Health (OSCR) leadership

    Joanna Deetrup's questions to Oscar Health (OSCR) leadership • Q1 2025

    Question

    Joanna Deetrup of Bank of America inquired about Oscar's perspective on the final provisions of CMS's proposed program integrity rule, its potential enrollment impact, the outlook for the extension of enhanced subsidies, and the percentage of Oscar's membership that is fully subsidized.

    Answer

    CEO Mark Bertolini expressed support for CMS's integrity goals but voiced concern that a shortened enrollment window could harm consumers. CFO Scott Blackley confirmed they are planning for the limitation of the continuous SEP in 2025. Regarding subsidies, Blackley stated that a significant portion of Oscar's book has always received subsidies but did not provide a specific percentage, noting the outcome is intertwined with the new integrity rules.

    Ask Fintool Equity Research AI